The annual pay of GSK’s chief executive could rise to nearly £22m in three years’ time as the pharmaceutical company attempts to offer US-style pay packets to top executives.
Emma Walmsley’s package could increase to a maximum of £21.56m if the company’s share price rises by at least 50% and it hits stretching targets, according to its annual report.